全文获取类型
收费全文 | 16316篇 |
免费 | 5520篇 |
国内免费 | 33篇 |
学科分类
医药卫生 | 21869篇 |
出版年
2024年 | 129篇 |
2023年 | 1049篇 |
2022年 | 362篇 |
2021年 | 660篇 |
2020年 | 1196篇 |
2019年 | 404篇 |
2018年 | 1098篇 |
2017年 | 1174篇 |
2016年 | 1413篇 |
2015年 | 1369篇 |
2014年 | 1934篇 |
2013年 | 2115篇 |
2012年 | 644篇 |
2011年 | 557篇 |
2010年 | 1085篇 |
2009年 | 1497篇 |
2008年 | 569篇 |
2007年 | 357篇 |
2006年 | 660篇 |
2005年 | 280篇 |
2004年 | 224篇 |
2003年 | 149篇 |
2002年 | 134篇 |
2001年 | 264篇 |
2000年 | 229篇 |
1999年 | 242篇 |
1998年 | 319篇 |
1997年 | 246篇 |
1996年 | 232篇 |
1995年 | 192篇 |
1994年 | 150篇 |
1993年 | 109篇 |
1992年 | 110篇 |
1991年 | 88篇 |
1990年 | 105篇 |
1989年 | 81篇 |
1988年 | 65篇 |
1987年 | 48篇 |
1986年 | 56篇 |
1985年 | 45篇 |
1984年 | 41篇 |
1983年 | 39篇 |
1982年 | 15篇 |
1980年 | 16篇 |
1979年 | 10篇 |
1978年 | 12篇 |
1977年 | 18篇 |
1976年 | 11篇 |
1975年 | 15篇 |
1972年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
Dietary fiber has important health benefits in childhood, especially in promoting normal laxation. Currently, children consume amounts of dietary fiber that appear to be inadequate for optimal health promotion and disease prevention. It is prudent to recommend that children older than 2 years of age increase dietary fiber intake to an amount equal to or greater than their age + 5 g/day. According to the “age + 5” rule dietary fiber intake would increase from 8 g/day at age 3 years to 25 g/day by age 20 years. After age 20, dietary fiber levels of 25 to 35 g/day are recommended. Dietary fiber intake should be increased gradually in childhood by increasing consumption of a variety of fruits, vegetables, legumes, cereals, and other whole-grain products. Although very high fiber intake in childhood could have adverse effects, the potential health benefits of a moderate increase in dietary fiber substantially outweigh the possible risks, especially in highly industrialized countries such as the United States. A safe range of dietary fiber intake for children may be between age + 5 and age + 10 g/day. This range is considered safe even for children and adolescents with marginal intakes of some vitamins and minerals; should provide enough dietary fiber for normal laxation; and may provide enough added dietary fiber to help prevent chronic diseases.J Am Diet Assoc. 1995; 1140-1146, 1149. 相似文献
93.
94.
95.
Occupational exposure to HIV is becoming a daily hazard in many emergency departments. Emergency physicians who are protected by disability insurance policies are likely to believe that if they are unable to continue working because of HIV-positive status, their disability policies will provide them with a source of income. Unfortunately, analysis of case law regarding claims under disability policies shows that the law is unlikely to consider an asymptomatic, HIV-positive physician disabled for purposes of payments under disability policies. Therefore, it is necessary for emergency physicians to make sure this issue is resolved before buying and relying on a disability policy so that an anticipated safety net will be operative over the full range of hazards that emergency physicians face.[Lavely R: The HIV-positive physician and disability insurance. Ann Emerg Med June 1994;23:1355-1362.] 相似文献
96.
97.
Dr. Christiane Sanchez-Menegay MD Esther S. Hudes PhD MPH Steven R. Cummings MD 《Journal of general internal medicine》1992,7(4):432-434
To describe the determinants of patient satisfaction with medical care, self-administered questionnaires were given to a consecutive sample of 237 patients coming to an ambulatory care practice for the treatment of upper respiratory infections (URIs). Patients' most important goal was to obtain a diagnosis (57%). They usually got more reassurance, medication, and personal interest than they had expected (p = 0.0001). In a multivariate model, patients' satisfaction was related to the degrees of personal interest and reassurance they had received and to whether they felt they had received the right medication (r2 = 0.45, p = 0.0001). The authors concluded that patients with URIs generally want a diagnosis but are primarily satisfied by the personal interest, the reassurance, and the medication they receive. 相似文献
98.
Jungsun Park MD PhD Naomi Hisanaga MD Yangho Kim MD MPH 《American journal of industrial medicine》2009,52(8):625-632
Many corporations move their manufacturing facilities or technologies from developed to developing countries. Stringent regulations have made it costly for industries to operate in developed, industrialized countries. In addition, labor costs are high in these countries, and there is increasing awareness among the general public of the health risks associated with industry. The relocation of hazardous industries to developing countries is driven by economic considerations: high unemployment, a cheaper labor force, lack of regulation, and poor enforcement of any existing regulations make certain countries attractive to business. The transfer of certain industries from Japan to Korea has also brought both documented occupational diseases and a new occupational disease caused by chemicals without established toxicities. Typical examples of documented occupational diseases are carbon disulfide poisoning in the rayon manufacturing industry, bladder cancer in the benzidine industry, and mesothelioma in the asbestos industry. A new occupational disease due to a chemical without established toxicities is 2‐bromopropane poisoning. These examples suggest that counter‐measures are needed to prevent the transfer of occupational health problems from a developed to a developing country. Corporate social responsibility should be emphasized, close inter‐governmental collaboration is necessary and cooperation among non‐governmental organizations is helpful. Am. J. Ind. Med. 52:625–632, 2009. © 2009 Wiley‐Liss, Inc. 相似文献
99.
R. Parker Ward MD Mouaz H. Al-Mallah MD Gabriel B. Grossman MD PhD Christopher L. Hansen MD Robert C. Hendel MD Todd C. Kerwin MD Benjamin D. McCallister Jr MD Rupa Mehta MD Donna M. Polk MD MPH Peter L. Tilkemeier MD Aseem Vashist MD Kim Allan Williams MD David G. Wolinsky MD Edward P. Ficaro PhD 《Journal of nuclear cardiology》2007,14(6):911-e38
100.
TRACY B. BRAMLETTE MD MPH DAVID H. LAWSON MD CARL V. WASHINGTON MD EMIR VELEDAR PHD BARRY R. JOHNS MD STACEY F. BRISMAN MD LIANA ABRAMOVA MD SUEPHY C. CHEN MD MS 《Dermatologic surgery》2007,33(1):11-16
BACKGROUND: Patients with thick (Breslow>4 mm) primary melanoma and/or regional nodal metastasis have a high risk of tumor recurrence. High-dose adjuvant interferon (IFN) alfa-2b offers/=50% risk of recurrence/disease-related mortality and offered IFN. Telephone surveys delineated reasons behind patients' decisions to accept IFN. RESULTS: Acceptors, 60 of 135 (45%), decided to take IFN alfa-2b whereas 75 of 135 (55%) declined. Being female (OR, 2.4; 95% CI, 1.17-5.03; p=.017) and positive SLN status (OR, 2.2; 95% CI, 1.01-4.97; p=.048) were strongly associated with patients who chose IFN. Acceptors of IFN were younger, more influenced by physicians, and less affected by depression and side effect profile (p<.05 for all). Decliners were more concerned by strained relationships with family and social life (p<.05). CONCLUSIONS: Gender and positive SLN were predictive of high-risk melanoma patients' acceptance of IFN treatment. Physician insight into melanoma patients' therapeutic decision-making process can guide patients through this difficult disease. 相似文献